Vimarsana
Biggest News Aggregation in the World

Page 2 - Frequentis Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Frequentis Group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Frequentis Group Today - Breaking & Trending Today

Attractive Growth Opportunities In Remote Towers Market discussed in a new research report - Vimarsana News

Attractive Growth Opportunities In Remote Towers Market discussed in a new research report

Remote Towers Market by Operation Type (Single, Multiple, Contingency), System Type (Airport Equipment, Remote Tower Modules, Solutions & Software), Application (Communication, Information & Control, Surveillance) and Region - Global Forecast to 2027

One Year of A-SMGCS Level 4 Operations at Abu Dhabi International Airport, UAE - Vimarsana News

One Year of A-SMGCS Level 4 Operations at Abu Dhabi International Airport, UAE

Global Air Navigation Services, and ATRiCS of the Frequentis Group, have delivered operational and safety benefits to Abu Dhabi Airports

FREQUENTIS A-SMGCS at Abu Dhabi International Airport - Vimarsana News

FREQUENTIS A-SMGCS at Abu Dhabi International Airport

One year of A-SMGCS Level 4 operations at Abu Dhabi International Airport, UAE

FREQUENTIS' Order Intake Exceeds €400m for the First Time - Vimarsana News

FREQUENTIS' Order Intake Exceeds €400m for the First Time

Revenues rose 15.7% to €386m and Europe accounted for 65%, the Americas for 16%, Asia for 12%, and Australia/Pacific/Africa for 7%.

21st Austria weekly - Marinomed, Wolford, Frequentis (12/04/2023) - Vimarsana News

21st Austria weekly - Marinomed, Wolford, Frequentis (12/04/2023)

21st Austria weekly - Marinomed Wolford Frequentis 12/04/2023 [pic1]Marinomed: Science-based biotech company Marinomed Biotech AG listed on the Vienna Stock Exchange announced further positive results from its clinical study anti-allergic properties of Carragelose nasal spray. The open-label cross-over randomized trial conducted at Challenge Chamber showed that spray can significantly decrease symptoms allergic rhinitis hay fever in patients challenged with their respective allergen. These show exerts a barrier function is not only effective shielding mucosa respiratory viruses but also...